132 results on '"Ueki, Keisuke"'
Search Results
2. DNA demethylation is associated with malignant progression of lower-grade gliomas
3. PATH-23. HIGHLY INFILTRATING OLIGODENDROGLIOMAS SHOW DIFFERENT MORPHOLOGY FROM TYPICAL OLIGODENDROGLIOMAS WHILE MAINTAINING GOOD RESPONSE TO CHEMO-RADIATION THERAPY
4. Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells
5. Classification of adult diffuse gliomas by molecular markers—a short review with historical footnote
6. RADT-23. RECURRENT OLIGODENDROGLIOMAS AFTER FIRST CHEMO-RADIATION THERAPY RESPONDED REMARKABLY TO RE-RADIATION
7. Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial
8. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p
9. Symptomatic Recurrence of Intracranial Arterial Dissections: Follow-Up Study of 143 Consecutive Cases and Pathological Investigation
10. Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients
11. PATH-08. EVALUATION OF MISMATCH REPAIR GENE EXPRESSION BY IMMUNOHISTOCHEMISTRY MAY DETECT EARLY PHASE OF MMR DEFICIENCY IN RECURRENT GLIOMAS
12. NIMG-29. DEVELOPING AUTOMATIC SEGMENTATION METHOD FOR BRAIN TUMOR MR IMAGES THAT CAN BE USED AT MULTIPLE FACILITIES
13. PATH-10. EFFECTS OF 19q-LOSS IN IDH-MUTATED ASTROCYTOMAS ON BETTER PROGNOSIS AND OLIGODENDROGLIOMA-LIKE MORPHOLOGY
14. MPC-11 Comprehensive gene expression analysis of IDH-mutated astrocytomas with 19q-loss
15. Peculiar Characteristics of Arteriovenous Malformations Arising in the Galenic Region
16. Genetic Alteration of Poly(ADP-ribose) Polymerase-1 in Human Germ Cell Tumors
17. Selective Expression of a Subset of Neuronal Genes in Oligodendroglioma with Chromosome 1p Loss
18. Risk of Subarachnoid Hemorrhage From a De Novo Aneurysm
19. Risk of Aneurysm Recurrence in Patients With Clipped Cerebral Aneurysms: Results of Long-Term Follow-Up Angiography
20. Results of radiosurgery for brain stem arteriovenous malformations
21. Clinicopathological Study of Intracranial Fusiform and Dolichoectatic Aneurysms: Insight on the Mechanism of Growth
22. 10070: MET-02 NON-SMALL-CELL LUNG CANCER WITH SYNCHRONOUS BRAIN METASTASIS IN THE ERA OF MOLECULAR TARGETED DRUGS: TREATMENT OUTCOME AND RISK FACTORS
23. MPC-07 MECHANISMS OF BETTER PROGNOSIS IN IDH-MUTATED ASTROCYTOMA WITH 19Q-LOSS
24. PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA
25. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
26. A Transcript Map of the Chromosome 19q-Arm Glioma Tumor Suppressor Region
27. EHD2, EHD3, and EHD4 Encode Novel Members of a Highly Conserved Family of EH Domain-Containing Proteins
28. IMMU-58. REDUCED NEOANTIGEN EXPRESSION AS A POSSIBLE IMMUNE EVASION MECHANISM DURING GLIOMA PROGRESSION
29. IDH‐mutated astrocytomas with 19q‐loss constitute a subgroup that confers better prognosis
30. A Multicenter Phase I/II Study of the BCNU Implant (Gliadel ® Wafer) for Japanese Patients with Malignant Gliomas
31. Additional file 2: Figure S1. of Genetic and epigenetic stability of oligodendrogliomas at recurrence
32. Intravascular Lymphoma with an Acute Course of Cerebellar Hemorrhage: A Case Report
33. Additional file 3: Figure S1. of A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
34. GENE-10. CHARACTERISTIC MOLECULAR PROFILE CHANGES IN PRIMARY AND RECURRENT GLIOMAS DEPENDING ON THEIR HISTOPATHOLOGY
35. GENE-60. INTEGRATED GENOMIC AND EPIGENOMIC ANALYSIS FOR HEMANGIOBLASTOMAS OF THE CENTRAL NERVOUS SYSTEM
36. PATH-21. IDH-MUTATED, 19q DELETED, TP53 MUTATED ANAPLASTIC GLIOMAS CONSTITUTE A SUBGROUP THAT LOOK LIKE AND BEHAVE LIKE ANAPLASTIC OLIGODENDROGLIOMAS
37. PATH-28. CLINICAL AND GENETIC CHARACTERISTICS OF DIFFUSE MIDLINE GLIOMA IN THE SPINAL CORD
38. Differences in genetic and epigenetic alterations between von Hippel–Lindau disease–related and sporadic hemangioblastomas of the central nervous system
39. Genetic and epigenetic stability of oligodendrogliomas at recurrence
40. GENT-23. MOLECULAR PATHOLOGICAL ANALYSIS ON IDH-WILDTYPE ADULT LOW-GRADE GLIOMAS
41. MNGO-06. CLINICAL COURSE OF GRADE II MENINGIOMAS INDICATE POSSIBILITY OF OVER DIAGNOSIS
42. MPTH-12. TERT PROMOTER MUTATION IS A POOR PROGNOSTIC MARKER FOR GBMS AND INTERACTS WITH MGMT METHYLATION STATUS
43. CSIG-06. BRACHYURY AND ITS UPSTREAM, PI3K/AKT PATHWAY, ARE INVOLVED IN GROWTH OF SKULL BASE CHORDOMA
44. Classification of adult diffuse gliomas by molecular markers—a short review with historical footnote
45. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
46. LG-54GENOMIC PROFILES OF PEDIATRIC LOW GRADE GLIOMAS IN JAPAN: A NON-NGS APPROACH
47. Differences in genetic and epigenetic alterations between von Hippel–Lindau disease–related and sporadic hemangioblastomas of the central nervous system.
48. NIMG-6811C-METHIONIN-PET ENABLES EARLY DETECTION AND SUBSEQUENT INTERVENTION OF RECURRENCE IN 1p/19q CO-DELETED GLIOMAS
49. MPTH-02MOLECULAR CLASSIFICATION BASED ON IDH1/2 AND TERT PROMOTER WELL-DEFINES SUBGROUPS WITH DIFFERENT OUTCOME IN ADULT DIFFUSE GLIOMAS: A REPORT FROM GLIOMA MOLECULAR CLASSIFICATION CONSORTIUM
50. A novel procedure for reconstruction utilizing superficial femoral vein grafts followingen blocresection of carotid artery and head and neck malignant tumours
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.